CTLA4 and metastatic melanoma: Research studies have reported that the human intestinal microbiota structure is related to antitumor efficacy in metastatic melanoma patients exposed to anti- cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and anti-programmed cell death protein 1 (PD-1) monoclonal antibodies [116,117,118].